Trial NCT05552157

View at ClinicalTrials.gov 
Org. Study IDs: DIAN-TU-002
Secondary IDs: 5U01AG059798

Last trial update was posted on 2024-03-05

MeSH Interventions

Antibodies, Monoclonal

MeSH Conditions

Alzheimer Disease Dementia

Other Conditions

Alzheimers Disease Alzheimers Disease, Familial

Stopping Reasons

Roche announced a decision to discontinue most of the company's global trials of gantenerumab. The DIAN-TU has paused the DIAN-TU-002 Primary Prevention Trial related to gantenerumab while considering other potential options for this platform trial.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID